FirmaIQ
Org.nr 979 455 518 2020 → 2021 Year-over-year analysis

ACD PHARMACEUTICALS AS: årsregnskap 2021 vs 2020

Shrank 26% on revenue, weaker earnings

approved 2022-06-30; registry 2022-08-15; journal 2022 866218

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2021 with 2020 for ACD PHARMACEUTICALS AS. Revenue 17.08m NOK → 12.71m NOK (-25.6%). Net result +9.12m NOK → +1.14m NOK. Equity 11.89m NOK → 13.03m NOK.

On the constructive side: equity strengthened. Pressures included: revenue fell; operating result weakened; net result weakened.

Also worth watching: cogs fell; headcount (årsverk) changed. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.

At a glance

Scorecard

Revenue
17.08m NOK 12.71m NOK
-25.6%
Operating result
+11.32m NOK +1.29m NOK
-88.6%
Net result
+9.12m NOK +1.14m NOK
-87.4%
Equity
11.89m NOK 13.03m NOK
+9.6%
Cash
10.42m NOK 10.20m NOK
-2.1%
Total assets
25.54m NOK 16.20m NOK
-36.5%

What improved

  • ↑

    Equity strengthened

    Book equity 11.89m NOK → 13.03m NOK (equity ratio 46.6% → 80.4%). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 17.08m NOK to 12.71m NOK (-25.6% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result +11.32m NOK → +1.29m NOK (op. margin 66.3% → 10.1%). Calculated

  • ↓

    Net result weakened

    Net result +9.12m NOK → +1.14m NOK (net margin 53.4% → 9.0%). Calculated

  • ↓

    Cash fell

    Bank deposits 10.42m NOK → 10.20m NOK (-2.1% YoY). Calculated

Things to notice

  • ·

    COGS fell

    COGS / varekostnad 580.7k NOK → 46.4k NOK (-92.0% YoY). Calculated

  • ·

    Headcount (årsverk) changed

    Reported FTEs 0.5 → 5. Reported fact